Home / Products / Cancer / Chronic lymphocytic leukemia

Chronic lymphocytic leukemia


Available treatments for Chronic lymphocytic leukemia
You can order a treatment for Chronic lymphocytic leukemia via TheSocialMedwork if it has not been approved and/or is not available in the patient's country. TheSocialMedwork - helping patients and doctors access the latest approved medicines and at the lowest price possible worldwide.
pill
View Product

Venclexta / Venclyxto

(venetoclax)

by: AbbVie
for: Blood Cancer
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

pill
View Product

Venclexta / Venclyxto

(venetoclax)

by: AbbVie
for: Blood Cancer
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

unknown
Enquire now

We may still be able to get it for you, provided that:

• it hasn't been approved and/or isn't available in your country
• you and your treating doctor have evaluated that the medicine is suitable for you, and your doctor writes a prescription for it.


About chronic lymphocytic leukemia

Chronic Lymphocytic Leukemia (CLL) is a slow-growing disease in which too many immature lymphocytes (white blood cells, which are cells of the immune system of the body) are found mostly in the blood and bone marrow [1]. Sometimes, in later stages of the disease, cancer cells are found in the lymph nodes and the disease is called small lymphocytic lymphoma. A leukemia is a type of cancer that develops in blood-forming tissue, such as bone marrow. It is a disease that does not create lumps or tumours but is rather characterized by the large-scale production of abnormal and immature blood cells. In the event of acute leukemia, the immature blood cells increase rapidly, while in chronic leukemia the cells develop in a more normal manner, resulting in the disease taking longer to set in [1].

CLL is the most common form of leukemia in the Western world but is significantly less frequent in Asia. The disease is highly heterogeneous: some patients may never require therapy while others can progress rapidly and require therapy shortly after presentation [2]. It is estimated that in 2016 there will be 18,960 new cases of chronic lymphocytic leukemia and 4,660 deaths [3].

The above products may be suitable for treating patients with CLL. We recommend that you discuss the suitability of possible treatment options with your doctor. For further information please contact our support team at support@thesocialmedwork.com.


Registered with the Dutch Ministry of Health as an independent intermediary, Registration number 6730 BEM



Share our website

Follow us


DISCLAIMER: The Services of TheSocialMedwork do not replace a physician-patient relationship and are not intended as medical advice. TheSocialMedwork provides patients and physicians with existing treatment options abroad and creates access to these options after the patient and physician have made a professional decision. Privacy Policy / Terms and Conditions
Our service uses cookies.